Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and tlr4 signaling

Cancer Research

Volumn 74, Issue 5, 2014, Pages 1329-1337

  Hakim, Fahed ^a   Wang, Yang ^a   Zhang, Shelley X L ^a   Zheng, Jiamao ^a   Yolcu, Esma S ^b   Carreras, Alba ^a   Khalyfa, Abdelnaby ^a   Shirwan, Haval ^b   Almendros, Isaac ^a   Gozal, David ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POLARITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SLEEP DISORDER; SLEEP FRAGMENTATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; DISEASE PROGRESSION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASMS; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION; TOLL-LIKE RECEPTOR 4;

EID: 84896505624     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3014     Document Type: Article

References (46)

1. Abrams B. Cancer and sleep apnea-The hypoxia connection. Med Hypotheses 2007;68:232.
2. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-6.
3. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res 2005;65:9595-600.
4. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, et al. A prospective study of sleep duration and mortality risk in women. Sleep 2004;27:440-4.
5. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 2006;66:5521-5.
6. Chung SA, Wolf TK, Shapiro CM. Sleep and health consequences of shift work in women. J Womens Health (Larchmt) 2009;18: 965-77.
7. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-Analysis. J Sleep Res 2009;18:148-58.
8. Ikehara S, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 2009;32:295-301.
9. Kakizaki M, Kuriyama S, Sone T, Ohmori-Matsuda K, Hozawa A, Nakaya N, et al. Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 2008;99:1502-5.
10. Kripke DF, Langer RD, Elliott JA, Klauber MR, Rex KM. Mortality related to actigraphic long and short sleep. Sleep Med 2011;12:28-33.
11. Liang JA, Sun LM, Muo CH, Sung FC, Chang SN, Kao CH. Non-Apnea sleep disorders will increase subsequent liver cancer risk-A nationwide population-based cohort study. Sleep Med 2012;13:869-74.
12. McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM. Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 2006;15:241-9.
13. Sateia MJ, Lang BJ. Sleep and cancer: recent developments. Curr Oncol Rep 2008;10:309-18.
14. Thompson CL, Larkin EK, Patel S, Berger NA, Redline S, Li L. Short duration of sleep increases risk of colorectal adenoma. Cancer 2011;117:841-7.
15. Tu X, Cai H, Gao YT, Wu X, Ji BT, Yang G, et al. Sleep duration and its correlates in middle-Aged and elderly Chinese women: the Shanghai Women's Health Study. Sleep Med 2012;13:1138-45.
16. Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White DL, El-Serag HB. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer 2013;108:213-21.
17. Zhang X, Giovannucci EL, Wu K, Gao X, Hu F, Ogino S, et al. Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 2013;36:681-8.
18. Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med 2012;18:1249-60.
19. Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, et al. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2012;21:1002-11.
20. Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, Duran-Cantolla J, PenaMdeL,Masdeu MJ, et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Criti Care Med 2013;187:99-105.
21. Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farre R. Sleepdisordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. A J Respir Crit Care Med 2012;186:190-4.
22. Almendros I, Montserrat JM, Ramirez J, Torres M, Duran-Cantolla J, Navajas D, et al. Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur Respir J 2012;39:215-7.
23. Almendros I, Montserrat JM, Torres M, Dalmases M, Cabanas ML, Campos-Rodriguez F, et al. Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Respir Physiol Neurobiol 2013;186:303-7.
24. Bhaskara VK, Mohanam I, Rao JS, Mohanam S. Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells. PLoS ONE 2012;7:e30905.
25. Karoor V, Le M, Merrick D, Fagan KA, Dempsey EC, Miller YE. Alveolar hypoxia promotes murine lung tumor growth through a VEGFR-2/ EGFR-dependent mechanism. Cancer Prev Res 2012;5:1061-71.
26. Liu Y, Song X, Wang X, Wei L, Liu X, Yuan S, et al. Effect of chronic intermittent hypoxia on biological behavior and hypoxia-Associated gene expression in lung cancer cells. J Cell Biochem 2010;111: 554-63.
27. Malec V, Gottschald OR, Li S, Rose F, Seeger W, Hanze J. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med 2010;48:1626-35.
28. Diers AR, Vayalil PK, Oliva CR, Griguer CE, Darley-Usmar V, Hurst DR, et al. Mitochondrial bioenergetics of metastatic breast cancer cells in response to dynamic changes in oxygen tension: effects of HIF-1alpha. PLoS ONE 2013;8:e68348.
29. Ramesh V, Nair D, Zhang SX, Hakim F, Kaushal N, Kayali F, et al. Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-Alpha pathway. J Neuroinflamm 2012;9:91.
30. Zhang SX, Khalyfa A, Wang Y, Carreras A, Hakim F, Neel BA, et al. Sleep fragmentation promotes NADPH oxidase 2-mediated adipose tissue inflammation leading to insulin resistance in mice. Int J Obes. 2013 Jul 30. [Epub ahead of print].
31. Fukuda K, Kobayashi A, Watabe K. The role of tumor-Associated macrophage in tumor progression. Front Biosci (Schol Ed) 2012;4: 787-98.
32. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012;33:119-26.
33. Kaushal N, Ramesh V, Gozal D. Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia. Am J Physiol Regul, Integrat Comp Physiol 2012;303:R19-29.
34. Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011;278:16-27.
35. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
36. Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, et al. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol 2009;46:2876-84.
37. Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, et al. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res 2010;29:92.
38. Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013;14:1014-22.
39. Green CE, Liu T, Montel V, Hsiao G, Lester RD, Subramaniam S, et al. Chemoattractant signaling between tumor cells and macrophages regulates cancer cell migration, metastasis and neovascularization. PLoS ONE 2009;4:e6713.
40. Obeid E, Nanda R, Fu YX, Olopade OI. The role of tumor-Associated macrophages in breast cancer progression (review). Int J Oncol 2013;43:5-12.
41. Takahashi T, Ibata M, Yu Z, Shikama Y, Endo Y, Miyauchi Y, et al. Rejection of intradermally injected syngeneic tumor cells frommice by specific elimination of tumor-Associated macrophages with liposomeencapsulated dichloromethylene diphosphonate, followed by induction of CD11b(+)/CCR3(-)/Gr- 1(-) cells cytotoxic against the tumor cells. Cancer Immunol, Immunother 2009;58:2011-23.
42. Wang Y, Carreras A, Lee S, Hakim F, Zhang SX, Nair D, et al. Chronic sleep fragmentation promotes obesity in young adult mice. Obesity. 2013 Sep 13. [Epub ahead of print].
43. Howe LR, Subbaramaiah K, Hudis CA, Dannenberg AJ. Molecular pathways: adipose inflammation as a mediator of obesity-Associated cancer. Clin Cancer Res 2013;19:6074-83.
44. Nieman KM, Romero IL, Van Houten B, Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013;1831:1533-41.
45. Wagner M, Dudley AC. A three-party alliance in solid tumors: adipocytes, macrophages and vascular endothelial cells. Adipocyte 2013;2:67-73.
46. Gharib SA, Khalyfa A, Abdelkarim A, Bhushan B, Gozal D. Integrative miRNA-mRNA profiling of adipose tissue unravels transcriptional circuits induced by sleep fragmentation. PLoS ONE 2012;7:e37669.